Reimagining the landscape of therapeutic innovation, pharmaceutical biotechnology & drug discovery leverages molecular biology, genomics, and cell culture systems to create next-generation biopharmaceuticals. Monoclonal antibodies, recombinant proteins, and RNA-based therapies are now pivotal in treating complex diseases, including cancer and autoimmune disorders. High-throughput screening, structure-based drug design, and bioinformatics platforms expedite the identification of potent drug candidates. In Pharmaceutical Biotechnology & Drug Discovery, personalized medicine is also gaining traction through biomarkers and companion diagnostics, enabling tailored treatments. Furthermore, biotechnology enhances drug delivery via nanocarriers and controlled-release systems, improving efficacy and patient compliance. This evolving field plays a central role in shaping modern healthcare, offering precision, safety, and scalability in therapeutic development.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Advancement in dual lateral flow immunoassay design for sensitive, rapid detection of rotavirus and adenovirus in stool samples
Ayan Ahmed Isse, Genexus Biotech Company, Somalia
Title :
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Diversity analyses of microbial communities in Armanis gold-polymetallic mine and acid mine drainage: Bioremediation
Anna Khachatryan, SPC Armbiotechnology of NAS of Armenia, Armenia